Needham Reiterates Hold on Globus Medical
Portfolio Pulse from Benzinga Newsdesk
Needham analyst David Saxon has reiterated a Hold rating on Globus Medical (NYSE:GMED).

August 07, 2024 | 10:45 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst David Saxon has reiterated a Hold rating on Globus Medical (NYSE:GMED).
The reiteration of a Hold rating suggests that the analyst does not see significant upside or downside potential in the short term. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100